I N 1 978, a newly recognized type of acute leukemia, pre-B cell acute lymphocytic leukemia (ALL), was described. ' Recently, a remarkable difference in response to treatment has been noted between children with pre-B cell versus "null" (non-B, non-T, non-
pre-B)
cell ALL. 
MATERIALS AND METHODS

Cell Marker Studies
Cytogenetic Studies
Bone marrow aspirates were cultured in RPMI I 640 supplemented with 10% fetal calfserum for 24 hr at 37#{176}C, then exposed to colcemid (0.06 pg/mI) for 3.5 hr at 4#{176}C. Routine methods were employed for culture harvest, slide preparation, and GTG-banding.
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RESULTS
Chromosomal banding
